Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

Paolo Romita; Caterina Foti; Gianluca Calianno; Andrea Chiricozzi

doi:10.1111/dth.15610

Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

Paolo Romita^*, Caterina Foti, Gianluca Calianno, Andrea Chiricozzi

^*Autore corrispondente per questo lavoro

Facoltà di Medicina e Chirurgia "A.Gemelli"

University of Bari

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originale	Inglese
pagine (da-a)	e15610-N/A
Rivista	Dermatologic Therapy
Volume	35
Numero di pubblicazione	8
DOI	https://doi.org/10.1111/dth.15610
Stato di pubblicazione	Pubblicato - 2022

All Science Journal Classification (ASJC) codes

Dermatologia

Keywords

Antibodies
Antirheumatic Agents
Arthritis
HIV Infections
Humanized
Humans
Monoclonal
Psoriatic
Thalidomide
Treatment Outcome

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Accesso al documento

10.1111/dth.15610

Altri file e collegamenti

Cita questo

@article{5bf89a5a161745ddb10409a0aeab654e,

title = "Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast",

keywords = "Antibodies, Antirheumatic Agents, Arthritis, HIV Infections, Humanized, Humans, Monoclonal, Psoriatic, Thalidomide, Treatment Outcome, Antibodies, Antirheumatic Agents, Arthritis, HIV Infections, Humanized, Humans, Monoclonal, Psoriatic, Thalidomide, Treatment Outcome",

author = "Paolo Romita and Caterina Foti and Gianluca Calianno and Andrea Chiricozzi",

year = "2022",

doi = "10.1111/dth.15610",

language = "English",

volume = "35",

pages = "e15610--N/A",

journal = "Dermatologic Therapy",

issn = "1396-0296",

publisher = "John Wiley and Sons Inc",

number = "8",

}

TY - JOUR

T1 - Successful treatment with secukinumab in an HIV-positive psoriatic patient after failure of apremilast

AU - Romita, Paolo

AU - Foti, Caterina

AU - Calianno, Gianluca

AU - Chiricozzi, Andrea

PY - 2022

Y1 - 2022

KW - Antibodies

KW - Antirheumatic Agents

KW - Arthritis

KW - HIV Infections

KW - Humanized

KW - Humans

KW - Monoclonal

KW - Psoriatic

KW - Thalidomide

KW - Treatment Outcome

KW - Antibodies

KW - Antirheumatic Agents

KW - Arthritis

KW - HIV Infections

KW - Humanized

KW - Humans

KW - Monoclonal

KW - Psoriatic

KW - Thalidomide

KW - Treatment Outcome

UR - https://publicatt.unicatt.it/handle/10807/214031

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85131325919&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85131325919&origin=inward

U2 - 10.1111/dth.15610

DO - 10.1111/dth.15610

M3 - Article

SN - 1396-0296

VL - 35

SP - e15610-N/A

JO - Dermatologic Therapy

JF - Dermatologic Therapy

IS - 8

ER -